Healthtech is advancing at a remarkable pace, but true impact happens when science, business, and patient needs align. With more than two decades at this intersection—beginning in chemistry and toxicology research and evolving into executive leadership—I’ve seen firsthand that the best leaders are translators. By turning complex discoveries into practical solutions, I’ve helped scale enterprises, launch new diagnostics, and guide innovation from the lab bench to the marketplace. The future of healthtech depends not just on discovery, but on disciplined leadership that bridges vision with execution, ensuring breakthroughs reach the patients who need them most.

Eric Lloyd is a visionary healthcare executive with over two decades of experience leading strategic transformation across public, private, and digital health sectors. Renowned for his ability to build high-performing teams and forge impactful provider partnerships, Eric has consistently delivered operational excellence and financial growth in roles ranging from CEO of multibillion-dollar health plans to strategic advisor for emerging, venture-backed companies. His leadership has shaped value-based care models, reduced healthcare costs, and advanced innovations in maternal health, behavioral health, and primary care. With a strong foundation in health administration and a passion for improving community outcomes, Eric continues to redefine how healthcare organizations deliver meaningful, measurable results.

Brett Giffin is a dynamic and results-driven healthcare executive known for transforming complex challenges into growth opportunities across diagnostics, medical devices, and healthcare technology sectors. With a deep foundation in commercial strategy, operational execution, and global market expansion, Brett has consistently delivered enterprise value by leading high-performing teams, forging strategic partnerships, and driving innovation in regulated markets. His leadership is grounded in military discipline, entrepreneurial vision, and an unwavering focus on customer outcomes—making him a catalyst for sustainable growth and competitive advantage.

Maureen A. O’Mara, MBA, BSN, RN, CCM, is a seasoned healthcare executive and consultant with over four decades of expertise in transforming healthcare operations, improving patient outcomes, and driving compliance excellence. Known for her results-oriented leadership and innovative approach, Maureen has successfully led initiatives that enhanced quality metrics, reduced operational costs, and elevated organizational performance. With a deep understanding of case management, medical management, and analytics, she has consistently delivered strategic solutions that align clinical goals with business objectives. An advocate for continuous improvement, Maureen remains dedicated to advancing healthcare innovation and supporting organizations in achieving impactful results.

With over 52 years of experience, Gerry Hogue is a trailblazing executive, entrepreneur, and independent director who has transformed the healthcare and high-tech industries through innovative leadership and strategic expertise. As the co-founder and CEO of VieCure Inc., Gerry led the development of a patented AI-driven oncology platform, securing over $50 million in funding and revolutionizing cancer care delivery. His distinguished board service, including roles at Point Biopharma and Precision Cancer Technologies, reflects his commitment to driving growth, improving governance, and fostering innovation. Known for his strategic foresight, mentorship, and international expertise, Gerry continues to make an indelible impact on organizations striving for transformative growth.